Explorer
Debate: Experts share key points after vaccine approval
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
India
Indore Water Crisis: Contaminated Supply Causes Deaths, Authorities Face Severe Negligence Questions
Indore Water Crisis: Madhya Pradesh Govt Faces Probe Over Indore Water Deaths
Breaking: Jaipur Chomu Bulldozer Action Sends Strong Message Against Illegal Constructions
Indore Water Crisis: Cholera Bacteria Found in Narmada Supply, Several Dead
Breaking: Property Row Turns Fatal in Ghaziabad as Sons Hire Shooters to Kill Father
View More
Top Headlines
Technology
Cities
News
Cities

























